NEJM and The Lancet issue expressions of concern as researchers question where the company got its data on thousands of coronavirus patients.

Early career researchers face unique challenges when a senior collaborator becomes embroiled in allegations of scientific malpractice.

Scientists have raised questions about the dataset published in The Lancet last week that triggered the suspension of clinical trials around the world—and about Surgisphere Corporation, the company behind the study.

Administration officials and lawmakers say the move is to shore up national security threats, but university professors argue such cancellations represent targeted discrimination.

When 70 independent teams were tasked with analyzing identical brain images, no two teams chose the same approach and their conclusions were highly variable.

The study, conducted in Malawi, Kenya, and Ghana, did not obtain informed consent from each parent whose child participated, but rather considered consent “implied” because of the particular experimental design.

After the initial announcements of two retractions, scientists have mobilized to interrogate the data in nearly 150 of Jonathan Pruitt’s papers.

The Department of Justice also released the names of two Chinese researchers who allegedly acted against US interests.

Four University of Florida faculty members leave their jobs as a state committee that formed last month pledges to investigate individual researchers and institutions.